BD Research Cloud 7.0 introduces Horizon Panel Maker to automate complex experiment setup
BD launches an AI-powered panel design tool for flow cytometry. Find out how it’s reshaping immunology and cancer research automation.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Ozelle’s 100B-image diagnostic AI platform puts scale and precision at the center of care
Ozelle’s AI-powered CBM platform debuts at WHX Dubai 2026. Discover how modular, guided diagnostics are transforming primary and veterinary care workflows.
Medical Devices & Diagnostics
Natera’s lung transplant biomarker study validates noninvasive dd-cfDNA surveillance model
Can a blood test replace lung biopsies? Natera’s Prospera test may reshape transplant care. Learn what the latest study means for diagnostics in organ health.
Pharma & Biotech
Genethon advances Duchenne gene therapy trial while licensing Pompe tech to Bayer’s AskBio
Genethon advances gene therapies for Duchenne and Pompe disease. Find out what its nonprofit model and AskBio licensing deal mean for rare disease care.
Pharma & Biotech
Eisai and Biogen advance injectable Alzheimer’s therapy with FDA fast-track decision
FDA fast-tracks Eisai’s LEQEMBI IQLIK for at-home Alzheimer’s care. Find out what this means for patients, payers, and delivery models today.
Pharma & Biotech
Landmark FDA nod gives MSC developers long-awaited quality benchmark for clinical use
The FDA has recognized Tasly’s 3P assay as the first quality control standard for MSCs. Find out what this changes for developers and regulators.
Pharma & Biotech
Argo Biopharma’s RNAi therapy targets Lp(a): What Phase 2b with Novartis could prove
Novartis advances Argo Biopharma’s BW-20829 into Phase 2b to target lipoprotein(a). Explore what this means for RNAi adoption in cardiovascular therapeutics.
Pharma & Biotech
Is oral GLP-1 finally viable? Inside Ascletis Pharma’s U.S. trial for ASC30
Ascletis starts U.S. Phase II trial of ASC30 in type 2 diabetes. Find out what this oral GLP-1R agonist could mean for the future of metabolic therapies.
Pharma & Biotech
FDA priority review for Leqembi Iqlik could transform Alzheimer’s drug initiation at home
Leqembi Iqlik gets FDA Priority Review for at-home Alzheimer’s treatment initiation. Find out what this could mean for patients, payers, and the care model.
Medical Devices & Diagnostics
Can edge AI help redefine acute care? What GE HealthCare and NXP’s anesthesia and NICU concepts reveal
When GE HealthCare and NXP Semiconductors N.V. took the stage at CES 2026 to showcase their collaboration, it marked more than a moment of tech theater. The partnership unveiled two forward-looking concept technologies that aim to apply edge artificial intelligence to some of the most demanding environments in medicine: the operating room and the neonatal